secwatch / observer
8-K filed August 11, 2022, 7:59 PM ET ticker BTCY CIK 0001630113
leadership confidence high sentiment neutral materiality 0.40

Two Biotricity directors resign; Chester White appointed to board

BIOTRICITY INC.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Patricia Kennedy

Director and member of Audit Committee and Nominating and Corporate Governance Committee
BTCY · BIOTRICITY INC.
Effective
2022-08-05
Successor
Chester White
Filed
August 11, 2022, 7:59 PM ET
On August 5, 2022, Patricia Kennedy as a member of the Board of Directors of Biotricity Inc. (the “Company”), a member of the Company’s Audit Committee, and a member of the Company’s Nominating and Corporate Governance Committee, resigned from the Company’s Board of Directors effective August 5, 2022.
Appointed

Chester White

Director
BTCY · BIOTRICITY INC.
Effective
2022-08-11
Filed
August 11, 2022, 7:59 PM ET
On August 11, 2022, the Board of Directors of the Company appointed Chester White to the Board of Directors to fill the vacancy created by Patricia Kennedy’s resignation.
Departed

Norman Betts

Director and member of Audit Committee
BTCY · BIOTRICITY INC.
Effective
2022-08-05
Filed
August 11, 2022, 7:59 PM ET
On August 5, 2022, Norman Betts as a member of the Board of Directors of Biotricity Inc. (the “Company”) and a member of the Company’s Audit Committee, resigned from the Company’s Board of Directors effective August 5, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Patricia Kennedy resigned as Director and member of Audit Committee and Nominating and Corporate Governance Committee at BIOTRICITY INC..

Action
resigned
Role
Director and member of Audit Committee and Nominating and Corporate Governance Committee
Exact text from the filing
On August 5, 2022, Patricia Kennedy as a member of the Board of Directors of Biotricity Inc. (the “Company”), a member of the Company’s Audit Committee, and a member of the Company’s Nominating and Corporate Governance Committee, resigned from the Company’s Board of Directors effective August 5, 2022.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Chester White was appointed as Director at BIOTRICITY INC..

Action
appointed
Role
Director
Exact text from the filing
On August 11, 2022, the Board of Directors of the Company appointed Chester White to the Board of Directors to fill the vacancy created by Patricia Kennedy’s resignation.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Norman Betts resigned as Director and member of Audit Committee at BIOTRICITY INC..

Action
resigned
Role
Director and member of Audit Committee
Exact text from the filing
On August 5, 2022, Norman Betts as a member of the Board of Directors of Biotricity Inc. (the “Company”) and a member of the Company’s Audit Committee, resigned from the Company’s Board of Directors effective August 5, 2022.
View on SEC.gov

BIOTRICITY INC. filing history →

Source: SEC EDGAR
accession 0001493152-22-022061
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.